SC 13G/A: PRECIGEN, INC.

Ticker: PGEN · Form: SC 13G/A · Filed: Feb 27, 2024 · CIK: 1356090

Precigen, Inc. SC 13G/A Filing Summary
FieldDetail
CompanyPrecigen, Inc. (PGEN)
Form TypeSC 13G/A
Filed DateFeb 27, 2024
Risk Levellow
Pages5
Reading Time6 min
Sentimentneutral

Sentiment: neutral

Topics: sc-13g-a

AI Summary

SC 13G/A filing by PRECIGEN, INC..

Risk Assessment

Risk Level: low

FAQ

What type of filing is this?

This is a SC 13G/A filing submitted by Precigen, Inc. (ticker: PGEN) to the SEC on Feb 27, 2024.

What is the risk level of this SC 13G/A filing?

This filing has been assessed as low risk.

How long is this filing?

Precigen, Inc.'s SC 13G/A filing is 5 pages with approximately 1,455 words. Estimated reading time is 6 minutes.

Where can I view the full SC 13G/A filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Stats: 1,455 words · 6 min read · ~5 pages · Grade level 10.7 · Accepted 2024-02-27 13:48:40

Filing Documents

(a)

ITEM 1(a). NAME OF ISSUER: PRECIGEN, INC.

(b)

ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 20374 Seneca Meadows Parkway, Germantown, Maryland 20876

(a)

ITEM 2(a). NAME OF PERSON FILING: Patient Capital Management, LLC Patient Opportunity Trust, a series of Advisor Managed Portfolios

(b)

ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 1 South Street, Suite 2550 Baltimore, MD 21202

(c)

ITEM 2(c). CITIZENSHIP: Delaware Delaware

(d)

ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock

(e)

ITEM 2(e). CUSIP NUMBER: 74017N105 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [X] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [X] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution: ITEM 4. (a) Amount beneficially owned: 1) Patient Capital Management, LLC is deemed to be the beneficial owner of 15,983,700 shares of common stock. 2) Patient Opportunity Trust is deemed to be beneficial owner of 13,000,000 shares of common stock. (b) Percent of class: 1) Patient Capital Management, LLC - 6.42% 2) Patient Opportunity Trust - 5.22% (c) Number of shares as to which the person has: (i) sole power to vote or to direct the vote: Patient Capital Management, LLC : 15,983,700 Patient Opportunity Trust, a series of Advisor Managed Portfolios : (ii) shared power to vote or to direct the vote: Patient Cap

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.